NOVONIX Statistics
Total Valuation
NOVONIX has a market cap or net worth of $192.23 million. The enterprise value is $221.63 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
NOVONIX has 567.94 million shares outstanding. The number of shares has increased by 1.93% in one year.
Current Share Class | n/a |
Shares Outstanding | 567.94M |
Shares Change (YoY) | +1.93% |
Shares Change (QoQ) | +3.26% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 495.60M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 32.83 |
Forward PS | n/a |
PB Ratio | 1.40 |
P/TBV Ratio | 1.53 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 37.86 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.52.
Current Ratio | 1.24 |
Quick Ratio | 1.10 |
Debt / Equity | 0.52 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -15.36 |
Financial Efficiency
Return on equity (ROE) is -46.54% and return on invested capital (ROIC) is -14.71%.
Return on Equity (ROE) | -46.54% |
Return on Assets (ROA) | -13.90% |
Return on Invested Capital (ROIC) | -14.71% |
Return on Capital Employed (ROCE) | -30.25% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.02 |
Inventory Turnover | 0.78 |
Taxes
In the past 12 months, NOVONIX has paid $97,687 in taxes.
Income Tax | 97,687 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.66% in the last 52 weeks. The beta is 1.31, so NOVONIX's price volatility has been higher than the market average.
Beta (5Y) | 1.31 |
52-Week Price Change | -48.66% |
50-Day Moving Average | 1.33 |
200-Day Moving Average | 1.69 |
Relative Strength Index (RSI) | 43.65 |
Average Volume (20 Days) | 92,543 |
Short Selling Information
Short Interest | 373,630 |
Short Previous Month | 353,807 |
Short % of Shares Out | 0.07% |
Short % of Float | 0.08% |
Short Ratio (days to cover) | 2.60 |
Income Statement
In the last 12 months, NOVONIX had revenue of $5.85 million and -$74.82 million in losses. Loss per share was -$0.15.
Revenue | 5.85M |
Gross Profit | 4.08M |
Operating Income | -54.41M |
Pretax Income | -46.45M |
Net Income | -74.82M |
EBITDA | -50.46M |
EBIT | -54.41M |
Loss Per Share | -$0.15 |
Full Income Statement Balance Sheet
The company has $42.56 million in cash and $71.45 million in debt, giving a net cash position of -$28.90 million or -$0.05 per share.
Cash & Cash Equivalents | 42.56M |
Total Debt | 71.45M |
Net Cash | -28.90M |
Net Cash Per Share | -$0.05 |
Equity (Book Value) | 137.59M |
Book Value Per Share | 0.24 |
Working Capital | 11.06M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$40.42 million and capital expenditures -$29.91 million, giving a free cash flow of -$70.32 million.
Operating Cash Flow | -40.42M |
Capital Expenditures | -29.91M |
Free Cash Flow | -70.32M |
FCF Per Share | -$0.12 |
Full Cash Flow Statement Margins
Gross Margin | 69.76% |
Operating Margin | -929.39% |
Pretax Margin | -1,276.38% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NOVONIX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.93% |
Shareholder Yield | n/a |
Earnings Yield | -38.92% |
FCF Yield | -36.58% |
Analyst Forecast
The average price target for NOVONIX is $4.00, which is 247.83% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.00 |
Price Target Difference | 247.83% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
NOVONIX has an Altman Z-Score of -0.68 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.68 |
Piotroski F-Score | 3 |